BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 17689030)

  • 1. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
    Forni F; Ferrandina G; Deodato F; Macchia G; Morganti AG; Smaniotto D; Luzi S; D'Agostino G; Valentini V; Cellini N; Giardina B; Scambia G
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1145-9. PubMed ID: 17689030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
    Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
    Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
    Chan YM; Ng TY; Ngan HY; Wong LC
    Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
    Arlt A; Luckhaupt H; Hildmann H
    Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A; Nakano T; Morita S; Oka K
    Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
    Micke O; Prott FJ; Schäfer U; Tangerding S; Pötter R; Willich N
    Anticancer Res; 2000; 20(6D):5113-5. PubMed ID: 11326679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer.
    Gitsch G; Kainz C; Joura E; Fröhlich B; Bieglmayr C; Tatra G
    Anticancer Res; 1992; 12(4):1247-9. PubMed ID: 1503417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
    Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
    Gadducci A; Tana R; Fanucchi A; Genazzani AR
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S23-6. PubMed ID: 17727924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H; Schwörer D; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
    Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
    Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK; Wu LY; Sun YC; Li B; Zhang HT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The SCC antigen is not a reliable tumor marker in the ENT area. Value of squamous cell carcinoma antigen in diagnosis and follow-up of squamous epithelial carcinoma in the head-neck area. Results of a retrospective study over 6 years].
    Gotschuli A; Anderhuber W; Danninger R; Habermann W
    Laryngorhinootologie; 1998 Mar; 77(3):165-7. PubMed ID: 9577824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
    Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
    Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Lee CC; Tang SG; Hsueh S
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):492-9. PubMed ID: 15925454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Ferrandina G; Macchia G; Legge F; Deodato F; Forni F; Digesù C; Carone V; Morganti AG; Scambia G
    Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.